• Tuesday,September 24,2024
ururembotoursandtravel.com
X

The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer

$ 20.99

5 (244) In stock

Share

Review: biological implications of oncogenic rearrangements in non-small cell lung cancer - Di Marco - Precision Cancer Medicine

Frontiers Neoadjuvant therapy in non-small cell lung cancer: basis, promise, and challenges

Nature里程碑:非小细胞肺癌新靶点——CLIP1-LTK - 知乎

Department of Thoracic Oncology National Cancer Center Hospital East

IJMS, Free Full-Text

LTK and ALK promote neuronal polarity and cortical migration by inhibiting IGF1R activity

Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma - ScienceDirect

Cancers, Free Full-Text

Frontiers Recent progress in targeted therapy for non-small cell lung cancer

LC-SCRUM-Asiaの遺伝子スクリーニングで肺がんの新しいドライバー遺伝子「CLIP1-LTK融合遺伝子」を世界で初めて発見